IL1B and migraine disorder: The combination of n-3 fatty acids and nano-curcumin significantly reduced migraine attack frequency in a synergistic manner.The combination group showed a significantly greater reduction in serum levels of IL-1β compared to other treatment groups.Although the IL-1β gene expression was significantly reduced in the combination group initially, these differences were not significant after multiple testing Bonferroni corrections.